Low COVID-19 vaccine hesitancy in Brazil

• DOI: 10.1016/j.vaccine.2021.09.013
• Publication Date: 2021-09-07T01:47:43Z
• Authors: Daniella Campelo ...; Marcio Fernandes ...; Karla Gonçalves C...; Adriana Teixeira ...; Maria de Fátima J...; Dimitri Marques A...; Zina Maria Almeid...; Livia Almeida de ...; Margarida dos San...; Carlos Eduardo da...; Maria Elisabeth L...; Zilton Farias Mei...; Flavia Amendola A...; Livia de Rezende ...; Roberta Fernandes...; Saint Clair dos S...
• Keywords: Pandemic; Odds

The COVID-19 pandemic has affected the entire world, and vaccine emerged as a source of hope for return to normal life. Still, various countries have reported high hesitancy rates. It is important know profile in Brazil help design adequate communication strategies. A voluntary, anonymous online survey was conducted from January 22 29, 2021, including resident Brazilian adults assess factors related hesitancy. Sociodemographic epidemiological data were analyzed. bivariate analysis with independent variables, outcome variable, multivariate logistic model used calculated adjusted odds ratios. sample included 173,178 respondents, found 10.5%. principal associated following: assigning importance vaccinés efficacy (AOR = 16.39), fear adverse reactions 11.23), country origin 3.72). Other risk male gender 1.62), having children 1.29), 9 years schooling or less 1.31), living Central-West region 1.19), age ≥ 40 1.17), monthly income < U$788.68 1.13). two vaccines available Brazil, Covishield CoronaVac, showed similar confidence, 80.13% 76.36%, respectively, despite higher rejection latter Chinese origin. This confirms low rate among Brazilians allowed identification that can assist elaboration strategies increase adherence. National Institute Women, Children Adolescents Health Fernandes Figueira, FIOCRUZ, Rio de Janeiro, Brazil.